Bildkälla: Stockfoto

Moberg Pharma: Completed enrollment for the Phase 3 study in the US - Redeye

Redeye is encouraged to learn that Moberg Pharma has completed the enrollment to the Phase 3 study for MOB-015 in North America.

Redeye is encouraged to learn that Moberg Pharma has completed the enrollment to the Phase 3 study for MOB-015 in North America.
Börsvärldens nyhetsbrev
ANNONSER